Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbie G Majzner

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Nature Medicine|September 11, 2019
Clinical lessons learned from the first leg of the CAR T cell journeyRobbie G Majzner, Crystal L Mackall
Cancer Discovery|August 24, 2018
Tumor Antigen Escape from CAR T-cell TherapyRobbie G Majzner, Crystal L Mackall
Nature Biomedical Engineering|April 24, 2019
Programming CAR-T cells to kill cancerLouai Labanieh, Robbie G Majzner, Crystal L Mackall
Frontiers in Immunology|November 22, 2018
CAR T Cell Therapy for NeuroblastomaRebecca M Richards, Elena Sotillo, Robbie G Majzner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Immunotherapy of Neuroblastoma: Facts and HopesJohn Anderson, Robbie G Majzner, Paul M Sondel
Cancer Cell|April 4, 2017
Harnessing the Immunotherapy Revolution for the Treatment of Childhood CancersRobbie G Majzner, Sabine Heitzeneder, Crystal L Mackall
Annual Review of Cancer Biology|June 11, 2021
Immune-Based Approaches for the Treatment of Pediatric MalignanciesKristopher R Bosse, Robbie G Majzner, Crystal L Mackall, et al.
Cancer Immunology Research|April 4, 2018
Neurotoxicity Associated with a High-Affinity GD2 CAR-LetterRobbie G Majzner, Evan W Weber, Rachel C Lynn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2026
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's diseasePavle Boskovic, Rotem Shalita, Wenqing Gao, et al.
Nature Reviews. Clinical Oncology|November 23, 2022
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumoursChristian L Flugel, Robbie G Majzner, Giedre Krenciute, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Nature Medicine|September 11, 2019
Clinical lessons learned from the first leg of the CAR T cell journeyRobbie G Majzner, Crystal L Mackall
Cancer Discovery|August 24, 2018
Tumor Antigen Escape from CAR T-cell TherapyRobbie G Majzner, Crystal L Mackall
Nature Biomedical Engineering|April 24, 2019
Programming CAR-T cells to kill cancerLouai Labanieh, Robbie G Majzner, Crystal L Mackall
Frontiers in Immunology|November 22, 2018
CAR T Cell Therapy for NeuroblastomaRebecca M Richards, Elena Sotillo, Robbie G Majzner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Immunotherapy of Neuroblastoma: Facts and HopesJohn Anderson, Robbie G Majzner, Paul M Sondel
Cancer Cell|April 4, 2017
Harnessing the Immunotherapy Revolution for the Treatment of Childhood CancersRobbie G Majzner, Sabine Heitzeneder, Crystal L Mackall
Annual Review of Cancer Biology|June 11, 2021
Immune-Based Approaches for the Treatment of Pediatric MalignanciesKristopher R Bosse, Robbie G Majzner, Crystal L Mackall, et al.
Cancer Immunology Research|April 4, 2018
Neurotoxicity Associated with a High-Affinity GD2 CAR-LetterRobbie G Majzner, Evan W Weber, Rachel C Lynn, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2026
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's diseasePavle Boskovic, Rotem Shalita, Wenqing Gao, et al.
Nature Reviews. Clinical Oncology|November 23, 2022
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumoursChristian L Flugel, Robbie G Majzner, Giedre Krenciute, et al.
Pageof 6